PCNI3 COST-EFFECTIVENESS ANALYSIS OF ADVANCED NON-SMALL CELL LUNG CANCER TREATMENT WITH CISPLATIN-ETOPOSIDE, CISPLATIN-WINORELBINE AND CISPLATIN-GEMCYTABINE
Nov 1, 2004, 00:00
10.1016/S1098-3015(10)65747-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)65747-6/fulltext
Title :
PCNI3 COST-EFFECTIVENESS ANALYSIS OF ADVANCED NON-SMALL CELL LUNG CANCER TREATMENT WITH CISPLATIN-ETOPOSIDE, CISPLATIN-WINORELBINE AND CISPLATIN-GEMCYTABINE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65747-6&doi=10.1016/S1098-3015(10)65747-6
First page :
Section Title :
Open access? :
No
Section Order :
116